• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环氧化酶-2在人类宫颈癌中过度表达。

Cyclooxygenase-2 is overexpressed in human cervical cancer.

作者信息

Kulkarni S, Rader J S, Zhang F, Liapis H, Koki A T, Masferrer J L, Subbaramaiah K, Dannenberg A J

机构信息

Department of Medicine, New York Presbyterian Hospital-Cornell, New York 10021, USA.

出版信息

Clin Cancer Res. 2001 Feb;7(2):429-34.

PMID:11234900
Abstract

Multiple lines of evidence suggest that cyclooxygenase-2 (COX-2) is an important target for preventing epithelial malignancies. Little is known, however, about the expression of COX-2 in gynecological malignancies. By immunoblot analysis, COX-2 was detected in 12 of 13 cases of cervical cancer but was undetectable in normal cervical tissue. Immunohistochemistry revealed COX-2 in malignant epithelial cells. COX-2 was also expressed in cervical intraepithelial neoplasia. The mechanism by which COX-2 is up-regulated in cervical cancer is unknown. Because the epidermal growth factor (EGF) receptor is commonly overexpressed in cervical cancer, we investigated whether EGF could induce COX-2 in cultured human cervical carcinoma cells. Treatment with EGF markedly induced COX-2 protein, COX-2 mRNA, and stimulated COX-2 promoter activity. The induction of COX-2 by EGF was suppressed by inhibitors of tyrosine kinase activity, phosphatidylinositol 3-kinase, mitogen-activated protein kinase kinase, and p38 mitogen-activated protein kinase. Moreover, overexpressing dominant-negative forms of extracellular signal-regulated kinase 1, c-Jun NH2-terminal kinase, p38, and c-Jun blocked EGF-mediated induction of COX-2 promoter activity. Taken together, these findings suggest that deregulation of the EGF receptor signaling pathway may lead to enhanced COX-2 expression in cervical cancer.

摘要

多项证据表明,环氧化酶-2(COX-2)是预防上皮性恶性肿瘤的重要靶点。然而,关于COX-2在妇科恶性肿瘤中的表达情况却知之甚少。通过免疫印迹分析,在13例宫颈癌病例中有12例检测到COX-2,但在正常宫颈组织中未检测到。免疫组织化学显示恶性上皮细胞中有COX-2。COX-2在宫颈上皮内瘤变中也有表达。COX-2在宫颈癌中上调的机制尚不清楚。由于表皮生长因子(EGF)受体在宫颈癌中通常过度表达,我们研究了EGF是否能在培养的人宫颈癌细胞中诱导COX-2。用EGF处理显著诱导了COX-2蛋白、COX-2 mRNA,并刺激了COX-2启动子活性。酪氨酸激酶活性抑制剂、磷脂酰肌醇3激酶、丝裂原活化蛋白激酶激酶和p38丝裂原活化蛋白激酶可抑制EGF对COX-2的诱导。此外,过表达细胞外信号调节激酶1、c-Jun氨基末端激酶、p38和c-Jun的显性负性形式可阻断EGF介导的COX-2启动子活性诱导。综上所述,这些发现表明EGF受体信号通路失调可能导致宫颈癌中COX-2表达增强。

相似文献

1
Cyclooxygenase-2 is overexpressed in human cervical cancer.环氧化酶-2在人类宫颈癌中过度表达。
Clin Cancer Res. 2001 Feb;7(2):429-34.
2
Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells.通过过氧化物酶体增殖物激活受体γ调控人宫颈癌细胞中COX-2基因的表达
Clin Cancer Res. 2003 Oct 1;9(12):4627-35.
3
Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.15-脱氧-Δ12,14-前列腺素J2对结肠癌细胞中激活蛋白1激活、血管内皮生长因子及环氧化酶-2表达的抑制作用:一种氧化还原敏感的过氧化物酶体增殖物激活受体γ非依赖机制的证据
Cancer Res. 2004 Aug 1;64(15):5162-71. doi: 10.1158/0008-5472.CAN-04-0849.
4
Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.通过靶向人卵巢癌细胞中的内皮素A受体抑制环氧合酶-1和-2的表达
Clin Cancer Res. 2004 Jul 15;10(14):4670-9. doi: 10.1158/1078-0432.CCR-04-0315.
5
Ursolic acid inhibits cyclooxygenase-2 transcription in human mammary epithelial cells.熊果酸抑制人乳腺上皮细胞中环氧化酶-2的转录。
Cancer Res. 2000 May 1;60(9):2399-404.
6
Epidermal growth factor-induced cyclooxygenase-2 expression is mediated through phosphatidylinositol-3 kinase, not mitogen-activated protein/extracellular signal-regulated kinase kinase, in recurrent respiratory papillomas.在复发性呼吸道乳头状瘤中,表皮生长因子诱导的环氧化酶-2表达是通过磷脂酰肌醇-3激酶介导的,而非丝裂原活化蛋白/细胞外信号调节激酶激酶。
Clin Cancer Res. 2005 Sep 1;11(17):6155-61. doi: 10.1158/1078-0432.CCR-04-2664.
7
Retinoids suppress epidermal growth factor-induced transcription of cyclooxygenase-2 in human oral squamous carcinoma cells.维甲酸抑制人口腔鳞状癌细胞中表皮生长因子诱导的环氧化酶-2转录。
Cancer Res. 1997 Jul 15;57(14):2890-5.
8
Epidermal growth factor-induced cyclooxygenase-2 expression in oral squamous cell carcinoma cell lines is mediated through extracellular signal-regulated kinase 1/2 and p38 but is Src and nuclear factor-kappa B independent.表皮生长因子诱导口腔鳞状细胞癌细胞系中环氧合酶-2表达是通过细胞外信号调节激酶1/2和p38介导的,但与Src和核因子-κB无关。
Eur J Oral Sci. 2009 Oct;117(5):528-35. doi: 10.1111/j.1600-0722.2009.00669.x.
9
Bryostatin-1 stimulates the transcription of cyclooxygenase-2: evidence for an activator protein-1-dependent mechanism.苔藓抑素-1刺激环氧化酶-2的转录:一种依赖活化蛋白-1的机制的证据。
Clin Cancer Res. 2003 Oct 15;9(13):5036-43.
10
Cyclooxygenase-2 transcription is regulated by human papillomavirus 16 E6 and E7 oncoproteins: evidence of a corepressor/coactivator exchange.环氧化酶-2转录受人类乳头瘤病毒16型E6和E7癌蛋白调控:共抑制因子/共激活因子交换的证据
Cancer Res. 2007 Apr 15;67(8):3976-85. doi: 10.1158/0008-5472.CAN-06-4273.

引用本文的文献

1
Recent Advances in Nanoparticle and Nanocomposite-Based Photodynamic Therapy for Cervical Cancer: A Review.基于纳米颗粒和纳米复合材料的宫颈癌光动力疗法的最新进展:综述
Cancers (Basel). 2025 Aug 4;17(15):2572. doi: 10.3390/cancers17152572.
2
AILDE Computer-Aided Discovery of Novel Ibuprofen-Coumarin Antitumor Lead Compounds Targeting Cyclooxygenase-2.AILDE计算机辅助发现靶向环氧合酶-2的新型布洛芬-香豆素抗肿瘤先导化合物
ACS Omega. 2024 Sep 19;9(39):41021-41031. doi: 10.1021/acsomega.4c06596. eCollection 2024 Oct 1.
3
The Expression of Cyclooxygenase-2 in Cervical Intraepithelial Neoplasia and Cervical Cancer.
环氧化酶-2在宫颈上皮内瘤变及宫颈癌中的表达
Cureus. 2024 Aug 8;16(8):e66473. doi: 10.7759/cureus.66473. eCollection 2024 Aug.
4
EGFR and HER2 expression in cervical cancer patients in Ibadan, Nigeria.尼日利亚伊巴丹宫颈癌患者的表皮生长因子受体(EGFR)和人表皮生长因子受体2(HER2)表达情况
Ecancermedicalscience. 2023 Oct 2;17:1607. doi: 10.3332/ecancer.2023.1607. eCollection 2023.
5
The High-Risk Human Papillomavirus Type Influences the Tissue Microenvironment in Cervical Intraepithelial Neoplasia Grade 2.高危型人乳头瘤病毒影响宫颈上皮内瘤变2级的组织微环境。
Viruses. 2023 Sep 19;15(9):1953. doi: 10.3390/v15091953.
6
First study on the immunohistochemical expression of cyclooxygenase-2 and clinicopathological association in canine hepatoid gland neoplasms.犬类肝样腺肿瘤中环氧合酶-2免疫组化表达及其临床病理相关性的首次研究。
Vet World. 2022 Oct;15(10):2432-2441. doi: 10.14202/vetworld.2022.2432-2441. Epub 2022 Oct 20.
7
Identification of Immune and Hypoxia Risk Classifier to Estimate Immune Microenvironment and Prognosis in Cervical Cancer.鉴定免疫和缺氧风险分类器以评估宫颈癌的免疫微环境和预后
J Oncol. 2022 Oct 17;2022:6906380. doi: 10.1155/2022/6906380. eCollection 2022.
8
Human papillomavirus and cervical cancer: an insight highlighting pathogenesis and targeting strategies.人乳头瘤病毒与宫颈癌:对发病机制及靶向治疗策略的深入剖析
Virusdisease. 2022 Jun;33(2):132-154. doi: 10.1007/s13337-022-00768-w. Epub 2022 May 30.
9
Molecular Markers to Predict Prognosis and Treatment Response in Uterine Cervical Cancer.预测子宫颈癌预后和治疗反应的分子标志物
Cancers (Basel). 2021 Nov 17;13(22):5748. doi: 10.3390/cancers13225748.
10
Preliminary evaluation of anticancer efficacy of pioglitazone combined with celecoxib for the treatment of non-small cell lung cancer.吡格列酮联合塞来昔布治疗非小细胞肺癌的抗癌疗效初步评价。
Invest New Drugs. 2022 Feb;40(1):1-9. doi: 10.1007/s10637-021-01158-7. Epub 2021 Aug 2.